<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been proposed that the basic abnormality in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> may be a quantitative defect in endochondral new bone formation secondary to decreased synthesis of somatomedin (SM) or abnormal binding of SM to specific receptors </plain></SENT>
<SENT sid="1" pm="."><plain>To test this hypothesis, we have measured plasma SM levels and SM receptors on circulating mononuclear cells obtained from 5 achondroplastic dwarfs and 5 age-matched controls </plain></SENT>
<SENT sid="2" pm="."><plain>Plasma SM levels were 0.82 +/- 0.14 U/ml (mean +/- S.E.M.) for the <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplastic dwarfs</z:e> and 0.90 +/- 0.12 U/ml for the controls </plain></SENT>
<SENT sid="3" pm="."><plain>The specific binding of 125I-SM to 50 x 10(6) mononuclear cells was 7.66 +/- 1.11% for the dwarf group and 7.66 +/- 1.16% for the controls </plain></SENT>
<SENT sid="4" pm="."><plain>Achondroplastic and control cells possessed equal numbers of receptor sites and identical receptor affinity for SM </plain></SENT>
<SENT sid="5" pm="."><plain>The data indicate that plasma SM levels and SM binding to circulating mononuclear cells are <z:mpath ids='MPATH_458'>normal</z:mpath> in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplastic dwarfs</z:e> and suggest a primary intrace-lular defect </plain></SENT>
</text></document>